Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)
International Journal of Clinical Oncology · 2025
DOI: 10.1007/s10147-025-02759-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Kenji Tanabe und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Science Tokyo, Bunkyo-Ku, 1 - 5- 45, Yushima, Bunkyo-ku, Tokyo, 113 - 8510, Japan. Hauptthemen laut MEDLINE: Urologic Neoplasms, Carcinoma, Transitional Cell. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Oligo-metastatic urothelial carcinoma (OMUC), characterized by a limited number of metastases, demonstrates better survival outcomes compared to poly-metastatic urothelial carcinoma (PMUC), but some patients with OMUC exhibit poor prognosis. However, a comprehensive analysis of prognostic factors in OMUC remains lacking. This study aimed to determine prognostic factors in patients with OMUC from a multicenter dataset and evaluate the effect of existing predictive models. METHODS: This retrospective study included 443 patients with metastatic urothelial carcinoma (MUC) from 15 institutions (YUSHIMA study). OMUC involved cases with three or fewer metastases. Clinical data were analyzed for associations with overall survival (OS) utilizing Cox regression models. The effect of existing predictive models (Bajorin, Bellmunt, and Apolo) on OMUC prognosis was evaluated. RESULTS: Patients with OMUC (n = 182) demonstrated better Eastern Cooperative Oncology Group-performance status (ECOG-PS) and lower visceral metastasis frequency compared to PMUC (n = 261). Patients with OMUC exhibited a median OS of 26.1 months vs. 13.7 months for PMUC (p < 0.01). Poor ECOG-PS, liver metastasis, and hypoalbuminemia appeared as independent poor prognostic factors for OS in OMUC. The Bajorin, Bellmunt, and Apolo models significantly correlated with OS in patients with OMUC (p < 0.01, for all). CONCLUSION: Known prognostic factors for MUC were confirmed as significant prognostic factors for OS in OMUC, and existing prognostic models applied to OMUC. These results are expected to contribute to developing more effective treatment strategies for OMUC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Institute of Science Tokyo, Bunkyo-Ku, 1 - 5- 45, Yushima, Bunkyo-ku, Tokyo, 113 - 8510, Japan.
- Department of Urology, Institute of Science Tokyo, Bunkyo-Ku, 1 - 5- 45, Yushima, Bunkyo-ku, Tokyo, 113 - 8510, Japan. s-yoshida.uro@tmd.ac.jp.
- Department of Urology, Saitama Red Cross Hospital, Saitama, Japan.
- Department of Urology, Tsuchiura Kyodo General Hospital, Tsuchiura-shi, Ibaraki, Japan.
- Department of Urology, Soka Municipal Hospital, Soka-shi, Saitama, Japan.
- Department of Urology, JA Toride Medical Hospital, Toride-shi, Ibaraki, Japan.
Zitieren
APA
Tanabe, K., Yoshida, S., Kimura, T., Maezawa, Y., Ishihara, K., Inoue, N., Izumi, K., Fujiwara, M., Toide, M., Yamamoto, T., Uehara, S., Araki, S., Inoue, M., Takazawa, R., Numao, N., Ohtsuka, Y., Tanaka, H., & Fujii, Y. (2025). Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study). International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02759-5
Vancouver
Tanabe K, Yoshida S, Kimura T, Maezawa Y, Ishihara K, Inoue N, et al. Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study). International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02759-5
BibTeX
@article{Tanabe2025,
author = {Tanabe, Kenji and Yoshida, Soichiro and Kimura, Tomoki and Maezawa, Yuya and Ishihara, Kensaku and Inoue, Naoki and Izumi, Keita and Fujiwara, Motohiro and Toide, Masahiro and Yamamoto, Takanobu and Uehara, Sho and Araki, Saori and Inoue, Masaharu and Takazawa, Ryoji and Numao, Noboru and Ohtsuka, Yukihiro and Tanaka, Hajime and Fujii, Yasuhisa},
title = {Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)},
journal = {International Journal of Clinical Oncology},
year = {2025},
doi = {10.1007/s10147-025-02759-5}
}
EUVIMED